PASG — Passage Bio, Inc.

PASGPassage Bio, Inc.

NAS · US · Healthcare · Biotechnology · passagebio.com

5.770USD+0.26%Mkt Cap: 18.51M USDP/E: —Last update: 2026-06-01

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD c…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap18.51M USD

Enterprise Value-8.69M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-45.52M USD

Revenue/Share—

Last Price5.770 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees24

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.75

PEG—

EV/EBITDA0.23

EV/Revenue—

P/S—

P/B0.98

EPS (TTM)-11.84

EPS (Forward)-7.68

52W Range

3.93511% of range20.00

52W High20.00 USD

52W Low3.935 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-242.72%

ROA-73.09%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-31.51M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-71.05%

Net Debt-27.58M USD

Net Debt/EBITDA0.75

Balance Sheet

Debt/Equity1.28

Current Ratio1.73

Quick Ratio1.66

Book Value/Sh5.893 USD

Cash/Share10.39 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJul 14, 2025

Analyst Consensus

Rating—

Target (Mean)11.40 USD

Target Range7.000 USD – 23.00 USD

# Analysts5

Ownership

Shares Out.3.21M

Float2.89M

Insiders0.41%

Institutions58.33%

Short Interest

Short Ratio1.1d

Short % Float6.33%

Short % Out.5.07%

Shares Short162.63K

Short (prev mo.)68.09K

Technical

SMA 506.734 (-14.3%)

SMA 2008.518 (-32.3%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)117.17K

Avg Vol (10d)35.80K

Technical Indicators

RSI (14)50.4

MACD-0.2850

MACD Signal-0.5115

MACD Hist.+0.2265

BB Upper6.097 USD

BB Middle5.006 USD

BB Lower3.914 USD

BB Width43.61%

ATR (14)0.5102 USD

Vol Ratio (20d)0.33x